Phase I/II study of single agent Ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL) Meeting Abstract

  

Authors:	Grommes, C.; Gavrilovic, I.; Kaley, T.; Nolan, C.; Omuro, A.; Wolfe, J.; Pentsova, E.; Hatzoglou, V.; Mellinghoff, I.; DeAngelis, L.
Abstract Title:	Phase I/II study of single agent Ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
Meeting Title:	21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Journal Title:	Neuro-Oncology
Volume:	18
Issue:	Suppl. 6
Meeting Dates:	2016 Nov 17-20
Meeting Location:	Scottsdale, AZ
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2016-11-01
Start Page:	vi3
End Page:	vi4
Language:	English
ACCESSION:	WOS:000398604100013
PROVIDER:	wos
DOI:	10.1093/neuonc/now212.011
Notes:	Meeting Abstract: ACTR-12 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/110998